Ann Surg

1. SHANKAR S, Rammohan A, Gunasekaran V, Rajalingam R, et al
   Reappraising Liver Transplantation for Combined Hepatocellular-cholangiocarcinoma.
   Ann Surg. 2026 Oct 30. doi: 10.1097/SLA.0000000000007156.
   

   >> Share

   
   

   
   Clin Transplant

2. HAN H, Chacko KR, Orandi B, von Ahrens DE, et al
   Living Liver Donors With Obesity and Metabolic Risk: Review and Guidance on Donor Triage and Care.
   Clin Transplant. 2026;40:e70681.
   

   >> Share

   
   

   
   PLoS One

3. ULUK D, Liu W, Jiang D, Stoppe C, et al
   MIF inhibitor ISO-1 attenuates ischemia-reperfusion injury in a rat model of donation after circulatory death liver transplantation.
   PLoS One. 2026;21:e0361214.
   

   >> Share

   
   

   
   Transpl Int

4. COLUCCI N, Webb MA, Khalid MU, Giannou AD, et al
   Stereotactic body radiation therapy and radioembolization as bridging strategies to liver transplantation: a retrospective real-world analysis.
   Transpl Int. 2026;39:17047.
   

   >> Share

   
   
5. GRINSPAN LT, Zhang X, Dahhou M, Susal C, et al
   Differences in excess mortality by recipient sex after liver transplant.
   Transpl Int. 2026;39:16922.
   

   >> Share

   
   

   
   Transplant Proc

6. ZHONG X, Yan F, Yang X, Liu L, et al
   Effects of Base Excess Levels at the End of Anhepatic Stage on Early Hepatic and Renal Function After Liver Transplantation: A Single-Center Retrospective Cohort Study.
   Transplant Proc. 2026 Oct 29:S0041-1345(26)00537.
   

   >> Share

   
   
7. GARCIA JHP, Hyppolito EB, de Freitas LA Junior, Passos PRC, et al
   2,611 Liver Transplants: Indications and Survival Rates of a High-Volume Latin American Center.
   Transplant Proc. 2026 Oct 29:S0041-1345(26)00533.
   

   >> Share

   
   

   
   Transplantation

8. YAKUBU I, Siddiqui MS
   Reply: Addressing the Role of Glucagon-like Peptide-1 Receptor Agonists in Liver Transplant Recipients.
   Transplantation. 2026 Oct 30. doi: 10.1097/TP.0000000000005938.
   

   >> Share

   
   
9. PATRONO D, Zanierato M, Romagnoli R
   From Ischemic Thresholds to Dynamic Assessment: How NRP Is revolutionizing DCD Liver Transplantation.
   Transplantation. 2026 Oct 29. doi: 10.1097/TP.0000000000005965.
   

   >> Share

   
   
10. ANOUTI A, Dahshi H, Bartlett JA, Danpanichkul P, et al
    MASLD Liver Transplant: Evolution of Frequency, Age Trends, and Factors Associated With Outcomes.
    Transplantation. 2026 Oct 29. doi: 10.1097/TP.0000000000005953.
    

    >> Share

    
    
11. ACEITUNO L, Vogelin M, Borda J, Koshy D, et al
    Beyond Abstinence: How Integrated Multidisciplinary Management Improves Long-term Post Liver Transplant Outcomes.
    Transplantation. 2026 Oct 28. doi: 10.1097/TP.0000000000005939.
    

    >> Share

    
    
12. LI W, Hartog H, Minetto J, Dip M, et al
    Incidence and Risk Factors of Hepatic Artery Thrombosis and Stenosis After Pediatric Liver Transplantation: Results From the HEPATIC Registry.
    Transplantation. 2026 Oct 28. doi: 10.1097/TP.0000000000005920.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share